Semaglutide is a GLP-1 receptor peptide studied for its role in appetite signalling, metabolic regulation, and body composition research.
Single peptide
£89
Insulin resistance, pre-diabetes, and the dietary and cellular fixes before medication becomes inevitable.
Body Composition & Metabolic Health
Blood sugar dysregulation is the single most common driver of modern chronic illness — yet most people only get told about it once it's already become type 2 diabetes. By then the intervention window has narrowed dramatically. Understanding insulin and glucose before the label arrives changes what's possible. This chapter is the earliest warning system health doesn't usually give you.
6 takeaways from this chapter.
Anyone with a family history of type 2 diabetes who wants to break the pattern. People whose blood work has been described as 'borderline' or 'within range but creeping up.' Anyone experiencing energy crashes after meals, brain fog by mid-afternoon, or stubborn midsection weight despite exercise.
Part of The Body Blueprint — 41 chapters across every system that matters. £6 per chapter, or £29 for the full bundle (save £217).
Build the natural foundation first — then layer the MYOTECH protocols matched to what you've just read.
Semaglutide is a GLP-1 receptor peptide studied for its role in appetite signalling, metabolic regulation, and body composition research.
Single peptide
£89
Tirzepatide is an advanced dual-action metabolic peptide studied for its role in appetite signalling, metabolic regulation, and body composition protocols.
Single peptide
£79 from
Individual chapters: £246 · Full Blueprint: £29 · Save £217 (88% off).